Your browser doesn't support javascript.
Equitable allocation of COVID-19 vaccines in the United States.
Schmidt, Harald; Weintraub, Rebecca; Williams, Michelle A; Miller, Kate; Buttenheim, Alison; Sadecki, Emily; Wu, Helen; Doiphode, Aditi; Nagpal, Neha; Gostin, Lawrence O; Shen, Angela A.
  • Schmidt H; Department of Medical Ethics and Health Policy, Center for Health Incentives and Behavioral Economics, Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia PA, USA. schmidth@mail.med.upenn.edu.
  • Weintraub R; Ariadne Labs, Brigham and Women's Hospital & Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Williams MA; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Miller K; Ariadne Labs, Brigham and Women's Hospital & Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Buttenheim A; Department of Family and Community Health, School of Nursing; Center for Health Incentives and Behavioral Economics; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia PA, USA.
  • Sadecki E; Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia PA, USA.
  • Wu H; School of Arts and Sciences, University of Pennsylvania, Philadelphia PA, USA.
  • Doiphode A; School of Arts and Sciences, University of Pennsylvania, Philadelphia PA, USA.
  • Nagpal N; School of Arts and Sciences, University of Pennsylvania, Philadelphia PA, USA.
  • Gostin LO; O'Neill Institute for National & Global Health Law, Georgetown University, Washington, DC, USA.
  • Shen AA; Vaccine Education Center, Children's Hospital of Philadelphia, Philadelphia PA, USA.
Nat Med ; 27(7): 1298-1307, 2021 07.
Artículo en Inglés | MEDLINE | ID: covidwho-1233717
ABSTRACT
Many vaccine rationing guidelines urge planners to recognize, and ideally reduce, inequities. In the United States, allocation frameworks are determined by each of the Centers for Disease Control and Prevention's 64 jurisdictions (50 states, the District of Columbia, five cities and eight territories). In this study, we analyzed vaccine allocation plans published by 8 November 2020, tracking updates through to 30 March 2021. We evaluated whether jurisdictions adopted proposals to reduce inequity using disadvantage indices and related place-based measures. By 30 March 2021, 14 jurisdictions had prioritized specific zip codes in combination with metrics such as COVID-19 incidence, and 37 jurisdictions (including 34 states) had adopted disadvantage indices, compared to 19 jurisdictions in November 2020. Uptake of indices doubled from 7 to 14 among the jurisdictions with the largest shares of disadvantaged communities. Five applications were distinguished (1) prioritizing disadvantaged groups through increased shares of vaccines or vaccination appointments; (2) defining priority groups or areas; (3) tailoring outreach and communication; (4) planning the location of dispensing sites; and (5) monitoring receipt. To ensure that equity features centrally in allocation plans, policymakers at the federal, state and local levels should universalize the uptake of disadvantage indices and related place-based measures.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Factores Socioeconómicos / Asignación de Recursos para la Atención de Salud / Vacunas contra la COVID-19 / COVID-19 / Política de Salud Tipo de estudio: Estudio experimental / Estudio observacional / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Nat Med Asunto de la revista: Biologia Molecular / Medicina Año: 2021 Tipo del documento: Artículo País de afiliación: S41591-021-01379-6

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Factores Socioeconómicos / Asignación de Recursos para la Atención de Salud / Vacunas contra la COVID-19 / COVID-19 / Política de Salud Tipo de estudio: Estudio experimental / Estudio observacional / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Nat Med Asunto de la revista: Biologia Molecular / Medicina Año: 2021 Tipo del documento: Artículo País de afiliación: S41591-021-01379-6